Joseph Michael Garasic, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Drug-Eluting Stents | 2 | 2021 | 681 | 0.690 |
Why?
|
| Cardiovascular Agents | 2 | 2021 | 842 | 0.680 |
Why?
|
| Renal Artery Obstruction | 3 | 2009 | 218 | 0.640 |
Why?
|
| Hemostasis, Surgical | 2 | 2009 | 126 | 0.590 |
Why?
|
| Angioplasty | 3 | 2014 | 356 | 0.530 |
Why?
|
| Femoral Artery | 3 | 2009 | 826 | 0.500 |
Why?
|
| Stents | 5 | 2014 | 3177 | 0.500 |
Why?
|
| Angioplasty, Balloon | 2 | 2009 | 589 | 0.390 |
Why?
|
| Hypertension, Renovascular | 2 | 2009 | 115 | 0.380 |
Why?
|
| Carotid Stenosis | 3 | 2014 | 859 | 0.350 |
Why?
|
| Axillary Vein | 1 | 2008 | 14 | 0.320 |
Why?
|
| Coronary Stenosis | 3 | 2009 | 802 | 0.310 |
Why?
|
| Endarterectomy, Carotid | 1 | 2014 | 554 | 0.310 |
Why?
|
| Aneurysm, False | 2 | 2008 | 255 | 0.300 |
Why?
|
| Subclavian Artery | 1 | 2007 | 133 | 0.270 |
Why?
|
| Equipment and Supplies | 1 | 2009 | 273 | 0.270 |
Why?
|
| Balloon Occlusion | 1 | 2007 | 125 | 0.260 |
Why?
|
| Punctures | 1 | 2007 | 366 | 0.260 |
Why?
|
| Music | 1 | 2008 | 245 | 0.250 |
Why?
|
| Angioplasty, Balloon, Coronary | 2 | 2008 | 1724 | 0.230 |
Why?
|
| Suture Techniques | 1 | 2008 | 768 | 0.220 |
Why?
|
| Renal Artery | 1 | 2004 | 351 | 0.210 |
Why?
|
| Peripheral Vascular Diseases | 2 | 2008 | 488 | 0.210 |
Why?
|
| Arterial Occlusive Diseases | 2 | 2022 | 749 | 0.200 |
Why?
|
| Sirolimus | 1 | 2009 | 1540 | 0.200 |
Why?
|
| Catheterization, Central Venous | 1 | 2007 | 526 | 0.200 |
Why?
|
| Vascular Surgical Procedures | 1 | 2009 | 1489 | 0.180 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2007 | 695 | 0.170 |
Why?
|
| Pyridazines | 1 | 2022 | 202 | 0.170 |
Why?
|
| Venous Thrombosis | 1 | 2008 | 1304 | 0.160 |
Why?
|
| Medical Errors | 1 | 2007 | 1263 | 0.160 |
Why?
|
| Hemorrhage | 2 | 2009 | 3422 | 0.160 |
Why?
|
| Ultrasonography, Doppler, Duplex | 2 | 2009 | 198 | 0.150 |
Why?
|
| Tunica Intima | 1 | 2000 | 458 | 0.150 |
Why?
|
| Williams Syndrome | 2 | 2009 | 194 | 0.140 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2022 | 686 | 0.140 |
Why?
|
| Arteriosclerosis | 1 | 2001 | 1056 | 0.130 |
Why?
|
| Vascular Diseases | 1 | 2004 | 1160 | 0.130 |
Why?
|
| Imidazoles | 1 | 2022 | 1173 | 0.130 |
Why?
|
| Catheters | 1 | 2018 | 426 | 0.130 |
Why?
|
| Embolism | 2 | 2009 | 399 | 0.120 |
Why?
|
| Arteries | 1 | 2000 | 1121 | 0.120 |
Why?
|
| Catheterization, Peripheral | 1 | 2018 | 343 | 0.120 |
Why?
|
| Recurrence | 3 | 2014 | 8456 | 0.110 |
Why?
|
| Embolic Protection Devices | 1 | 2013 | 42 | 0.110 |
Why?
|
| Angiography | 3 | 2018 | 1597 | 0.110 |
Why?
|
| Paclitaxel | 1 | 2021 | 1730 | 0.110 |
Why?
|
| Blood Proteins | 1 | 2018 | 1172 | 0.100 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2022 | 1549 | 0.100 |
Why?
|
| Retreatment | 1 | 2014 | 598 | 0.100 |
Why?
|
| Propensity Score | 2 | 2014 | 1913 | 0.080 |
Why?
|
| Brachiocephalic Trunk | 1 | 2009 | 40 | 0.080 |
Why?
|
| Radiography | 3 | 2009 | 6975 | 0.080 |
Why?
|
| Ischemic Attack, Transient | 1 | 2014 | 874 | 0.080 |
Why?
|
| Carotid Artery, Common | 1 | 2009 | 175 | 0.080 |
Why?
|
| Nifedipine | 1 | 2008 | 221 | 0.070 |
Why?
|
| Pipecolic Acids | 1 | 2008 | 77 | 0.070 |
Why?
|
| Coronary Angiography | 1 | 2018 | 4506 | 0.070 |
Why?
|
| Myxoma | 1 | 2007 | 114 | 0.070 |
Why?
|
| Peripheral Arterial Disease | 1 | 2018 | 1274 | 0.070 |
Why?
|
| Aged | 13 | 2022 | 169266 | 0.070 |
Why?
|
| Sheep | 1 | 2009 | 1436 | 0.070 |
Why?
|
| Enalapril | 1 | 2008 | 310 | 0.070 |
Why?
|
| Hemodynamics | 2 | 2023 | 4164 | 0.070 |
Why?
|
| Jugular Veins | 1 | 2007 | 210 | 0.060 |
Why?
|
| Calgranulin B | 1 | 2006 | 86 | 0.060 |
Why?
|
| Aged, 80 and over | 6 | 2022 | 58946 | 0.060 |
Why?
|
| Male | 18 | 2022 | 360675 | 0.060 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2022 | 5662 | 0.060 |
Why?
|
| Retinal Dysplasia | 1 | 2004 | 12 | 0.060 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2008 | 537 | 0.060 |
Why?
|
| Risk Assessment | 4 | 2014 | 24013 | 0.060 |
Why?
|
| Proteomics | 1 | 2018 | 3836 | 0.060 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2018 | 2254 | 0.060 |
Why?
|
| Hematoma | 1 | 2009 | 763 | 0.060 |
Why?
|
| Heart Neoplasms | 1 | 2007 | 364 | 0.060 |
Why?
|
| Vasodilator Agents | 1 | 2008 | 989 | 0.060 |
Why?
|
| Prosthesis Failure | 1 | 2009 | 1204 | 0.050 |
Why?
|
| Aortic Aneurysm | 1 | 2008 | 648 | 0.050 |
Why?
|
| Hospital Mortality | 2 | 2014 | 5296 | 0.050 |
Why?
|
| Polyethylene Glycols | 1 | 2008 | 1187 | 0.050 |
Why?
|
| Anticoagulants | 2 | 2008 | 4795 | 0.050 |
Why?
|
| Models, Animal | 1 | 2009 | 2114 | 0.050 |
Why?
|
| Heart Failure | 2 | 2023 | 11701 | 0.050 |
Why?
|
| Time Factors | 3 | 2014 | 39953 | 0.050 |
Why?
|
| Kidney | 2 | 2009 | 7034 | 0.050 |
Why?
|
| Pulmonary Edema | 1 | 2004 | 408 | 0.050 |
Why?
|
| Cardiovascular System | 1 | 2008 | 836 | 0.050 |
Why?
|
| Registries | 2 | 2014 | 8236 | 0.050 |
Why?
|
| Humans | 20 | 2023 | 761098 | 0.040 |
Why?
|
| Treatment Outcome | 5 | 2014 | 64670 | 0.040 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2007 | 1086 | 0.040 |
Why?
|
| Thrombocytopenia | 1 | 2008 | 1182 | 0.040 |
Why?
|
| Retrospective Studies | 5 | 2023 | 80673 | 0.040 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2007 | 1060 | 0.040 |
Why?
|
| Myocardial Infarction | 2 | 2014 | 11475 | 0.040 |
Why?
|
| Middle Aged | 10 | 2022 | 220835 | 0.040 |
Why?
|
| Antineoplastic Agents | 1 | 2022 | 13630 | 0.040 |
Why?
|
| Popliteal Artery | 1 | 2001 | 310 | 0.040 |
Why?
|
| Female | 11 | 2022 | 392458 | 0.040 |
Why?
|
| Intermittent Claudication | 1 | 2001 | 304 | 0.040 |
Why?
|
| Patient Selection | 2 | 2013 | 4245 | 0.040 |
Why?
|
| Coronary Vessels | 1 | 2009 | 3111 | 0.040 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2004 | 1432 | 0.040 |
Why?
|
| Risk Factors | 4 | 2014 | 74219 | 0.040 |
Why?
|
| Vascular Patency | 1 | 2001 | 911 | 0.040 |
Why?
|
| Hyperplasia | 1 | 2000 | 1150 | 0.030 |
Why?
|
| Vasculitis | 1 | 2000 | 522 | 0.030 |
Why?
|
| Blood Platelets | 1 | 2006 | 2477 | 0.030 |
Why?
|
| Diagnosis, Differential | 2 | 2007 | 12975 | 0.030 |
Why?
|
| Stroke | 2 | 2014 | 9720 | 0.030 |
Why?
|
| Models, Cardiovascular | 1 | 2000 | 983 | 0.030 |
Why?
|
| Rabbits | 1 | 2000 | 4749 | 0.030 |
Why?
|
| Contrast Media | 1 | 2007 | 5311 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2018 | 15513 | 0.030 |
Why?
|
| Lower Extremity | 1 | 2001 | 1201 | 0.030 |
Why?
|
| Cell Division | 1 | 2000 | 4451 | 0.030 |
Why?
|
| Intracranial Embolism | 1 | 2013 | 189 | 0.020 |
Why?
|
| Equipment Design | 1 | 2000 | 3509 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2006 | 12743 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2006 | 9416 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 1 | 2018 | 2181 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2023 | 6385 | 0.020 |
Why?
|
| Adult | 4 | 2022 | 221083 | 0.020 |
Why?
|
| United States | 2 | 2014 | 72337 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2009 | 310 | 0.020 |
Why?
|
| Hypertension | 1 | 2008 | 8537 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2018 | 39121 | 0.020 |
Why?
|
| Elastin | 1 | 2009 | 298 | 0.020 |
Why?
|
| Mesenteric Artery, Superior | 1 | 2007 | 96 | 0.020 |
Why?
|
| Aortography | 1 | 2009 | 421 | 0.020 |
Why?
|
| Mesenteric Vascular Occlusion | 1 | 2007 | 92 | 0.020 |
Why?
|
| Wounds and Injuries | 1 | 2000 | 2492 | 0.020 |
Why?
|
| Predictive Value of Tests | 2 | 2018 | 15308 | 0.020 |
Why?
|
| Embolectomy | 1 | 2007 | 130 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2006 | 6504 | 0.020 |
Why?
|
| Paresis | 1 | 2007 | 176 | 0.020 |
Why?
|
| Thrombosis | 1 | 2000 | 2944 | 0.020 |
Why?
|
| Arginine | 1 | 2008 | 921 | 0.010 |
Why?
|
| Chromosome Deletion | 1 | 2009 | 1386 | 0.010 |
Why?
|
| Syncope | 1 | 2007 | 428 | 0.010 |
Why?
|
| Lung | 1 | 2023 | 9979 | 0.010 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 2006 | 897 | 0.010 |
Why?
|
| Incidence | 1 | 2022 | 21357 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2007 | 20600 | 0.010 |
Why?
|
| Animals | 2 | 2009 | 168083 | 0.010 |
Why?
|
| Lectins, C-Type | 1 | 2006 | 585 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2001 | 15845 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 2007 | 1837 | 0.010 |
Why?
|
| Megakaryocytes | 1 | 2006 | 566 | 0.010 |
Why?
|
| Disease Progression | 1 | 2018 | 13506 | 0.010 |
Why?
|
| Heparin | 1 | 2008 | 1632 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 20120 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 4565 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2018 | 54419 | 0.010 |
Why?
|
| Sulfonamides | 1 | 2008 | 1977 | 0.010 |
Why?
|
| Prognosis | 1 | 2018 | 29672 | 0.010 |
Why?
|
| Myocardial Ischemia | 1 | 2008 | 2133 | 0.010 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2008 | 2130 | 0.010 |
Why?
|
| Child, Preschool | 2 | 2009 | 42217 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2009 | 5971 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2006 | 4008 | 0.010 |
Why?
|
| Acute Disease | 1 | 2006 | 7240 | 0.010 |
Why?
|
| Young Adult | 1 | 2022 | 59199 | 0.010 |
Why?
|
| Echocardiography | 1 | 2007 | 5006 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2006 | 9648 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2006 | 7574 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2006 | 22157 | 0.000 |
Why?
|
| Gene Expression Regulation | 1 | 2006 | 11856 | 0.000 |
Why?
|
| Brain | 1 | 2007 | 27097 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2007 | 36418 | 0.000 |
Why?
|